Skip to main content

Table 1 This table presents the selected previously unknown drug-disease pairs predicted by our method, we just show the clinical variables that contribute to the final repurposing possibility of each drug-disease pair in the table

From: Clinical connectivity map for drug repurposing: using laboratory results to bridge drugs and diseases

Laboratory result

 

Alkaline phosphatase

Cholesterol

Glucose

HDL

LDL

Triglycerides

Disease

Type 2 diabetes

\(\downarrow\)

\(\uparrow\)

\(\uparrow\)

\(\downarrow\)

\(\uparrow\)

\(\uparrow\)

Drug

Clopidogrel Hydrogen sulfate

–

\(\downarrow\)

–

–

\(\downarrow\)

–

Disease

Type 2 Diabetes

\(\downarrow\)

\(\uparrow\)

\(\uparrow\)

\(\downarrow\)

\(\uparrow\)

\(\uparrow\)

Drug

Doxycycline hyclate

–

–

\(\downarrow\)

–

–

–

Disease

Coronary heart disease

\(\uparrow\)

\(\uparrow\)

\(\uparrow\)

\(\downarrow\)

\(\uparrow\)

\(\uparrow\)

Drug

Alendronate sodium

\(\downarrow\)

–

–

\(\uparrow\)

–

–

Disease

Congestive heart failure

\(\uparrow\)

\(\uparrow\)

\(\uparrow\)

\(\downarrow\)

\(\uparrow\)

\(\uparrow\)

Drug

Alendronate sodium

\(\downarrow\)

–

–

\(\uparrow\)

–

–

Disease

Heart attack

\(\uparrow\)

\(\uparrow\)

\(\uparrow\)

\(\downarrow\)

\(\uparrow\)

\(\uparrow\)

Drug

Alendronate sodium

\(\downarrow\)

–

–

\(\uparrow\)

–

–